Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-volume Nasal Wash With Budesonide for CRSwNP
NCT05541419Unknown
- Sponsor
- Universidade Estadual de Londrina
- Start
- Aug 2018
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of EPI-EE in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Universidade Estadual de Londrina. Primary endpoint: Nasal Polyp Score at 16 weeks. Status: unknown.
02
Drugs
EPI-EE
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT05541419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05541419.